<?xml version="1.0" encoding="UTF-8"?>
<p>Upon investigation of its 
 <italic>in vivo</italic> efficacy, it was shown that hypertonic saline nasal irrigation was capable of reducing the duration of illness by 22%, over the counter medicine use by 36% and illness in household members by 35%. Thirty percent more individuals also saw a reduction in viral shedding by â‰¥0.5 log
 <sub>10</sub> per day, which could serve as a reason for the lowered transmission rates.
 <xref rid="viw216-bib-0176" ref-type="ref">
  <sup>176</sup>
 </xref> The result shown, however, was not necessarily always positive, as some studies into the hypertonic saline nebulization of children with respiratory syncytial virus bronchiolitis showed no significant alleviation of their symptoms.
 <xref rid="viw216-bib-0176" ref-type="ref">
  <sup>176</sup>
 </xref>
</p>
